Showing results (1-10 of 548) with videos related to

Sort By:
Pageof 55
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
The Journal of Antimicrobial Chemotherapy|December 17, 2020
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaBurcu Isler, Patrick Harris, Adam G Stewart, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Achromobacter Infections and Treatment OptionsBurcu Isler, Timothy J Kidd, Adam G Stewart, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2020
Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review and Meta-analysisBurcu Isler, Yukiko Ezure, Jose Luis García-Fogeda Romero, et al.
Current Opinion in Infectious Diseases|February 19, 2020
New treatment options for multiresistant gram negativesDavid L Paterson, Burcu Isler, Adam Stewart
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Completing the Picture-Capturing the Resistome in Antibiotic Clinical TrialsAdam G Stewart, Michael J Satlin, Sanmarié Schlebusch, et al.
Jac-Antimicrobial Resistance|July 5, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant EnterobacteralesDavid L Paterson, Burcu Isler, Patrick N A Harris
Expert Opinion on Pharmacotherapy|July 7, 2021
How urgent is the need for new antifungals?Adam G Stewart, David L Paterson
Antimicrobial Agents and Chemotherapy|October 17, 2018
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii InfectionsBurcu Isler, Yohei Doi, Robert A Bonomo, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidenceBurcu Isler, Zhenya Welyczko, Nicholas Jorgensen, et al.
Pageof 55